Lymphoid tissue structure and HIV-1 infection: Life or death for T cells

Trends in Immunology

Volumn 33, Issue 6, 2012, Pages 306-314

  Zeng, Ming ^a   Haase, Ashley T ^a   Schacker, Timothy W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CXCL13 CHEMOKINE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ANTIVIRAL THERAPY; CD4+ T LYMPHOCYTE; CELL DEATH; CELL DIVISION; CELL MIGRATION; CELL SURVIVAL; COLLAGEN SYNTHESIS; DISEASE COURSE; FIBROSIS; HALF LIFE TIME; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; LONG TERM CARE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; T LYMPHOCYTE; TISSUE STRUCTURE; VIRAL CLEARANCE; VIRUS REPLICATION;

ANIMALS; ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HIV-1; HOMEOSTASIS; HUMANS; LYMPHOID TISSUE; T-LYMPHOCYTES;

EID: 84861702017     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.04.002     Document Type: Review

References (105)

1. Robbins G.K., et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin. Infect. Dis. 2009, 48:350-361.
2. Valdez H. Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). AIDS Rev. 2002, 4:157-164.
3. Valdez H., et al. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 2002, 16:1859-1866.
4. Florence E., et al. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med. 2003, 4:255-262.
5. Moore R.D., Keruly J.C. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin. Infect. Dis. 2007, 44:441-446.
6. Kelley C.F., et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin. Infect. Dis. 2009, 48:787-794.
7. Butler S.L., et al. Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2011, 58:297-303.
8. Sterne J.A., et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009, 373:1352-1363.
9. Reuter S., et al. Risk factors associated with older age in treatment-naïve HIV-positive patients. Intervirology 2012, 55:147-153.
10. Schacker T.W., et al. Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. J. Infect. Dis. 2002, 186:1092-1097.
11. Estes J., et al. Collagen deposition limits immune reconstitution in the gut. J. Infect. Dis. 2008, 198:456-464.
12. Estes J.D., et al. The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. Semin. Immunol. 2008, 20:181-186.
13. Guadalupe M., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003, 77:11708-11717.
14. Tedaldi E.M., et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin. Infect. Dis. 2004, 38:1478-1484.
15. Rodriguez-Barradas M.C., et al. Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin. Infect. Dis. 2003, 37:438-447.
16. Schacker T., et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J. Infect. Dis. 1998, 178:1616-1622.
17. Posavad C.M., et al. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. J. Infect. Dis. 2004, 190:693-696.
18. Piketty C., et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm. Dis. 2004, 31:96-99.
19. Engels E.A., et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int. J. Cancer 2008, 123:187-194.
20. Baker J.V., et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008, 22:841-848.
21. Phillips A.N., et al. The role of HIV in serious diseases other than AIDS. AIDS 2008, 22:2409-2418.
22. Weber R., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 2006, 166:1632-1641.
23. Curran A., et al. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med. 2008, 9:609-615.
24. Schacker T.W., et al. Lymphatic tissue fibrosis is associated with reduced numbers of naïve CD4+ T cells in human immunodeficiency virus type 1 infection. Clin. Vaccine Immunol. 2006, 13:556-560.
25. Schacker T.W., et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J. Clin. Invest. 2002, 110:1133-1139.
26. Haase A.T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 1999, 17:625-656.
27. Diaz A., et al. Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients. AIDS 2010, 24:2029-2039.
28. Diaz A., et al. Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors. J. Infect. Dis. 2011, 203:810-813.
29. Estes J.D., et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 2006, 193:703-712.
30. Estes J.D., et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J. Infect. Dis. 2007, 195:551-561.
31. Nies-Kraske E., et al. Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J. Infect. Dis. 2009, 199:1648-1656.
32. Schacker T.W., et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. AIDS 2005, 19:2169-2171.
33. Zeng M., et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J. Clin. Invest. 2011, 121:998-1008.
34. Zeng M., et al. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012, 8:e1002437.
35. Takada K., Jameson S.C. Naïve T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 2009, 9:823-832.
36. Sprent J., et al. T cell homeostasis. Immunol. Cell Biol. 2008, 86:312-319.
37. Tan J.T., et al. IL-7 is critical for homeostatic proliferation and survival of naïve T cells. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:8732-8737.
38. Surh C.D., Sprent J. Homeostasis of naïve and memory T cells. Immunity 2008, 29:848-862.
39. Cui W., Kaech S.M. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol. Rev. 2010, 236:151-166.
40. Taylor J.J., Jenkins M.K. CD4+ memory T cell survival. Curr. Opin. Immunol. 2011, 23:319-323.
41. Haynes B.F., et al. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu. Rev. Immunol. 2000, 18:529-560.
42. den Braber I., et al. Maintenance of peripheral naïve T cells is sustained by thymus output in mice but not humans. Immunity 2012, 36:288-297.
43. Zhang Z.Q., et al. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:1154-1159.
44. Haynes B.F., et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J. Clin. Invest. 1999, 103:921.
45. Haynes B.F., Hale L.P. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol. Res. 1998, 18:175-192.
46. Wykrzykowska J.J., et al. Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J. Exp. Med. 1998, 187:1767-1778.
47. Douek D.C., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998, 396:690-695.
48. Richardson M.W., et al. T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection. DNA Cell Biol. 2004, 23:1-13.
49. Hatzakis A., et al. Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 2000, 355:599-604.
50. Pakker N.G., et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 1998, 4:208-214.
51. Bucy R.P., et al. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J. Clin. Invest. 1999, 103:1391-1398.
52. Arron S.T., et al. Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus. Eur. J. Immunol. 2005, 35:46-55.
53. Zhang L., et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J. Exp. Med. 1999, 190:725-732.
54. Walker R.E., et al. Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat. Med. 1998, 4:852-856.
55. Douek D.C., et al. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 2009, 60:471-484.
56. Deeks S.G., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004, 104:942-947.
57. Hunt P.W., et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 2003, 187:1534-1543.
58. Silvestri G., et al. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 2007, 117:3148-3154.
59. Hellerstein M.K., McCune J.M. T cell turnover in HIV-1 disease. Immunity 1997, 7:583-589.
60. Douek D.C., et al. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 2003, 21:265-304.
61. Grossman Z., et al. Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6314-6319.
62. Douek D.C. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 2003, 5:172-177.
63. Gretz J.E., et al. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 1997, 156:11-24.
64. Gretz J.E., et al. Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. J. Immunol. 1996, 157:495-499.
65. Kaldjian E.P., et al. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int. Immunol. 2001, 13:1243-1253.
66. Link A., et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naïve T cells. Nat. Immunol. 2007, 8:1255-1265.
67. Hayakawa M., et al. Direct contact between reticular fibers and migratory cells in the paracortex of mouse lymph nodes: a morphological and quantitative study. Arch. Histol. Cytol. 1988, 51:233-240.
68. Rathmell J.C., et al. IL-7 enhances the survival and maintains the size of naïve T cells. J. Immunol. 2001, 167:6869-6876.
69. Schluns K.S., et al. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat. Immunol. 2000, 1:426-432.
70. Sixt M., et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005, 22:19-29.
71. Katakai T., et al. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int. Immunol. 2004, 16:1133-1142.
72. Mempel T.R., et al. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004, 427:154-159.
73. Gretz J.E., et al. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 2000, 192:1425-1440.
74. Bajenoff M., et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006, 25:989-1001.
75. Moussion C., Girard J.P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011, 479:542-546.
76. Wendland M., et al. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 2011, 35:945-957.
77. Miyasaka M., Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 2004, 4:360-370.
78. von Andrian U.H., Mempel T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 2003, 3:867-878.
79. Forster R., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
80. Gunn M.D., et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999, 189:451-460.
81. Boyman O., et al. Homeostatic proliferation and survival of naïve and memory T cells. Eur. J. Immunol. 2009, 39:2088-2094.
82. O'Murchadha M.T., et al. The histologic features of hyperplastic lymphadenopathy in AIDS-related complex are nonspecific. Am. J. Surg. Pathol. 1987, 11:94-99.
83. Pantaleo G., et al. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 1993, 328:327-335.
84. Katakai T., et al. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J. Exp. Med. 2004, 200:783-795.
85. Gramaglia I., et al. Lymphotoxin alphabeta is expressed on recently activated naïve and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. J. Immunol. 1999, 162:1333-1338.
86. Ohshima Y., et al. Naïve human CD4+ T cells are a major source of lymphotoxin alpha. J. Immunol. 1999, 162:3790-3794.
87. Severe P., et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N. Engl. J. Med. 2010, 363:257-265.
88. Donaghy H., et al. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003, 101:4505-4511.
89. MacPherson P.A., et al. Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2001, 28:454-457.
90. Koesters S.A., et al. IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur. J. Immunol. 2006, 36:336-344.
91. Seggewiss R., et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 2007, 110:441-449.
92. Min D., et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002, 99:4592-4600.
93. Abrams D., et al. Interleukin-2 therapy in patients with HIV infection. N. Engl. J. Med. 2009, 361:1548-1559.
94. Weiss L., et al. In vivo expansion of naïve and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:10632-10637.
95. Fry T.J., et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003, 101:2294-2299.
96. Levy Y., et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J. Clin. Invest. 2009, 119:997-1007.
97. Vassena L., et al. Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2355-2360.
98. Giri S.N., et al. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem. Pharmacol. 1997, 54:1205-1216.
99. Munger J.S., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
100. Bonniaud P., et al. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 2005, 171:889-898.
101. Nakao A., et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest. 1999, 104:5-11.
102. Gressner A.M., et al. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 2002, 7:d793-d807.
103. Taniguchi H., et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur. Respir. J. 2010, 35:821-829.
104. Scandella E., et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. immunol. 2008, 9:667-675.
105. Dudakov J.A., et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 2012, 336:91-95.